PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice
BackgroundThe transcriptional factor peroxisome proliferator–activated receptor γ (PPARγ) is an important therapeutic target for the treatment of type 2 diabetes. However, the role of the PPARγ transcriptional activity remains ambiguous in its metabolic regulation.MethodsBased on the crystal structu...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01285/full |
_version_ | 1828497761122648064 |
---|---|
author | Fusheng Guo Shuangshuang Xu Yanlin Zhu Xing Zheng Yi Lu Jui Tu Ying He Lihua Jin Lihua Jin Yong Li |
author_facet | Fusheng Guo Shuangshuang Xu Yanlin Zhu Xing Zheng Yi Lu Jui Tu Ying He Lihua Jin Lihua Jin Yong Li |
author_sort | Fusheng Guo |
collection | DOAJ |
description | BackgroundThe transcriptional factor peroxisome proliferator–activated receptor γ (PPARγ) is an important therapeutic target for the treatment of type 2 diabetes. However, the role of the PPARγ transcriptional activity remains ambiguous in its metabolic regulation.MethodsBased on the crystal structure of PPARγ bound with the DNA target of PPARγ response element (PPRE), Arg134, Arg135, and Arg138, three crucial DNA binding sites for PPARγ, were mutated to alanine (3RA), respectively. In vitro AlphaScreen assay and cell-based reporter assay validated that PPARγ 3RA mutant cannot bind with PPRE and lost transcriptional activity, while can still bind ligand (rosiglitazone) and cofactors (SRC1, SRC2, and NCoR). By using CRISPR/Cas9, we created mice that were heterozygous for PPARγ-3RA (PPARγ3RA/+). The phenotypes of chow diet and high-fat diet fed PPARγ3RA/+ mice were investigated, and the molecular mechanism were analyzed by assessing the PPARγ transcriptional activity.ResultsHomozygous PPARγ-3RA mutant mice are embryonically lethal. The mRNA levels of PPARγ target genes were significantly decreased in PPARγ3RA/+ mice. PPARγ3RA/+ mice showed more severe adipocyte hypertrophy, insulin resistance, and hepatic steatosis than wild type mice when fed with high-fat diet. These phenotypes were ameliorated after the transcription activity of PPARγ was restored by rosiglitazone, a PPARγ agonist.ConclusionThe current report presents a novel mouse model for investigating the role of PPARγ transcription in physiological functions. The data demonstrate that the transcriptional activity plays an indispensable role for PPARγ in metabolic regulation. |
first_indexed | 2024-12-11T12:54:39Z |
format | Article |
id | doaj.art-637569d765eb465dbfda5ebb352d144c |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-12-11T12:54:39Z |
publishDate | 2020-08-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-637569d765eb465dbfda5ebb352d144c2022-12-22T01:06:37ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-08-011110.3389/fphar.2020.01285544063PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in MiceFusheng Guo0Shuangshuang Xu1Yanlin Zhu2Xing Zheng3Yi Lu4Jui Tu5Ying He6Lihua Jin7Lihua Jin8Yong Li9State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, ChinaState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, ChinaState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, ChinaState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, ChinaState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, ChinaDepartment of Diabetes Complications and Metabolism, Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, United StatesLaboratory Animal Center, Xiamen University, Xiamen, ChinaState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, ChinaDepartment of Diabetes Complications and Metabolism, Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, United StatesState Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, ChinaBackgroundThe transcriptional factor peroxisome proliferator–activated receptor γ (PPARγ) is an important therapeutic target for the treatment of type 2 diabetes. However, the role of the PPARγ transcriptional activity remains ambiguous in its metabolic regulation.MethodsBased on the crystal structure of PPARγ bound with the DNA target of PPARγ response element (PPRE), Arg134, Arg135, and Arg138, three crucial DNA binding sites for PPARγ, were mutated to alanine (3RA), respectively. In vitro AlphaScreen assay and cell-based reporter assay validated that PPARγ 3RA mutant cannot bind with PPRE and lost transcriptional activity, while can still bind ligand (rosiglitazone) and cofactors (SRC1, SRC2, and NCoR). By using CRISPR/Cas9, we created mice that were heterozygous for PPARγ-3RA (PPARγ3RA/+). The phenotypes of chow diet and high-fat diet fed PPARγ3RA/+ mice were investigated, and the molecular mechanism were analyzed by assessing the PPARγ transcriptional activity.ResultsHomozygous PPARγ-3RA mutant mice are embryonically lethal. The mRNA levels of PPARγ target genes were significantly decreased in PPARγ3RA/+ mice. PPARγ3RA/+ mice showed more severe adipocyte hypertrophy, insulin resistance, and hepatic steatosis than wild type mice when fed with high-fat diet. These phenotypes were ameliorated after the transcription activity of PPARγ was restored by rosiglitazone, a PPARγ agonist.ConclusionThe current report presents a novel mouse model for investigating the role of PPARγ transcription in physiological functions. The data demonstrate that the transcriptional activity plays an indispensable role for PPARγ in metabolic regulation.https://www.frontiersin.org/article/10.3389/fphar.2020.01285/fullPPARγDNA bindingtranscriptional activitymetabolic disordermutantobesity |
spellingShingle | Fusheng Guo Shuangshuang Xu Yanlin Zhu Xing Zheng Yi Lu Jui Tu Ying He Lihua Jin Lihua Jin Yong Li PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice Frontiers in Pharmacology PPARγ DNA binding transcriptional activity metabolic disorder mutant obesity |
title | PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice |
title_full | PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice |
title_fullStr | PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice |
title_full_unstemmed | PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice |
title_short | PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice |
title_sort | pparγ transcription deficiency exacerbates high fat diet induced adipocyte hypertrophy and insulin resistance in mice |
topic | PPARγ DNA binding transcriptional activity metabolic disorder mutant obesity |
url | https://www.frontiersin.org/article/10.3389/fphar.2020.01285/full |
work_keys_str_mv | AT fushengguo ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice AT shuangshuangxu ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice AT yanlinzhu ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice AT xingzheng ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice AT yilu ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice AT juitu ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice AT yinghe ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice AT lihuajin ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice AT lihuajin ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice AT yongli ppargtranscriptiondeficiencyexacerbateshighfatdietinducedadipocytehypertrophyandinsulinresistanceinmice |